Pressure BioSciences, Inc. (OTCMKTS:PBIO – Get Free Report)’s stock price passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.14 and traded as low as $0.03. Pressure BioSciences shares last traded at $0.04, with a volume of 516 shares changing hands.
Pressure BioSciences Price Performance
The firm has a market capitalization of $1.37 million, a PE ratio of -0.02 and a beta of -0.26. The company has a fifty day moving average of $0.03 and a 200-day moving average of $0.14.
Pressure BioSciences (OTCMKTS:PBIO – Get Free Report) last released its quarterly earnings data on Friday, September 6th. The company reported ($0.22) EPS for the quarter. The company had revenue of $0.35 million during the quarter.
About Pressure BioSciences
Pressure BioSciences, Inc develops and sells pressure-based platform solutions in the North America, Europe, and Asia. The company's pressure cycling technology (PCT) technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, including cells and tissues from human, animal, plant, and microbial sources.
Further Reading
- Five stocks we like better than Pressure BioSciences
- ESG Stocks, What Investors Should Know
- Edgewise Therapeutics Soars 50%: Key Reasons Behind the Surge
- What Investors Need to Know About Upcoming IPOs
- How the Fed’s Rate Cut Could Supercharge These 3 ETFs
- The Risks of Owning Bonds
- Microsoft Stock: 3 Reasons It’s Ready to Crush Q4
Receive News & Ratings for Pressure BioSciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pressure BioSciences and related companies with MarketBeat.com's FREE daily email newsletter.
